Neil A Came (Neil Came)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 3

Top Topics

Molecularly Imprinted

Multiple Myeloma

Top Venues

Cytometry. Part B, Clinical cytometry

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Kah Teong Soh, Neil A Came, Gregory E Otteson, Dragan Jevremovic, Min Shi, Horatiu Olteanu, Alessandro Natoni, Anand Lagoo, Edward Theakston, Jón Þórir Óskarsson, Malgorzata Gorniak, George Grigoriadis, Maria Arroz, Matthew Fletcher, Pei Lin, Peter Ludwig, Prashant Ramesh Tembhare, Reda Matuzeviciene, Mantas Radzevicius, Sigi Kay, Weina Chen, Carina Cabrita, Paul K Wallace
Evaluation of multiple myeloma measurable residual disease by high sensitivity flow cytometry: An international harmonized approach for data analysis. Cytometry. Part B, Clinical cytometry 102 (2) (2022)
Emma Bayly, Vuong Nguyen, Adrian Binek, Anna Piggin, Kylie Baldwin, David Westerman, Neil A Came
Validation of a modified pre-lysis sample preparation technique for flow cytometric minimal residual disease assessment in multiple myeloma, chronic lymphocytic leukemia, and B-non Hodgkin lymphoma. Cytometry. Part B, Clinical cytometry 98 (5) (2020)
Lucy Claire Fox, Michelle Tan, Anna L Brown, Peer Arts, Ella R Thompson, Georgina L Ryland, Jennifer Lickiss, Hamish S Scott, Nicola K Poplawski, Kerry Phillips, Neil A Came, Paul James, Stephen B Ting, David S Ritchie, Jeffrey Szer, Christopher N Hahn, Anthony Schwarer, Piers A Blombery
A synonymous GATA2 variant underlying familial myeloid malignancy with striking intrafamilial phenotypic variability. British journal of haematology 190 (5) (2020)